Matthew Gall's Insider Trades & SAST Disclosures
Matthew Gall's most recent trade in ITeos Therapeutics Inc was a trade of 145,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 7, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Matthew Gall.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ITeos Therapeutics Inc | Matthew Gall | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2025 | 145,000 | 145,000 | - | - | Stock Option (Right to Buy) | |
| ITeos Therapeutics Inc | Matthew Gall | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2025 | 24,000 | 89,429 | - | 0 | Common Stock | |
| ITeos Therapeutics Inc | Matthew Gall | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 7.73 per share. | 19 Nov 2024 | 5,000 | 65,429 | - | 7.7 | 38,635 | Common Stock |
| Expand Energy Corp. - Ordi... | Matthew M. Gallagher | Director | Grant, award, or other acquisition of securities at price $ 89.55 per share. | 06 Jun 2024 | 2,234 | 15,113 (0%) | 0% | 89.6 | 200,055 | Common Stock |
| ITeos Therapeutics Inc | Matthew Gall | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 163,200 | 163,200 | - | - | Stock Option (Right to Buy) | |
| ITeos Therapeutics Inc | Gall Matthew | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Dec 2023 | 41,000 | 60,429 | - | 0 | Common Stock | |
| Expand Energy Corp. - Ordi... | Matthew M. Gallagher | Director | Grant, award, or other acquisition of securities at price $ 79.17 per share. | 08 Jun 2023 | 2,842 | 12,879 (0%) | 0% | 79.2 | 225,001 | Common Stock |
| Pioneer Natural Resources Co. | Matthew M. Gallagher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 1,046 | 117,222 (0%) | 0% | 0 | Common Stock | |
| ITeos Therapeutics Inc | Matthew Gall | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2023 | 130,000 | 130,000 | - | - | Stock Option (Right to Buy) | |
| Expand Energy Corp. - Ordi... | Matthew M. Gallagher | Director | Grant, award, or other acquisition of securities at price $ 92.10 per share. | 09 Jun 2022 | 2,443 | 10,037 (0%) | 0% | 92.1 | 225,000 | Common Stock |
| Pioneer Natural Resources Co. | Matthew M. Gallagher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2022 | 891 | 116,176 (0%) | 0% | 0 | Common Stock | |
| ITeos Therapeutics Inc | Matthew Gall | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2022 | 85,000 | 85,000 | - | - | Stock Option (Right to Buy) | |
| Pioneer Natural Resources Co. | Matthew M. Gallagher | Director | Sale of securities on an exchange or to another person at price $ 240.11 per share. | 01 Mar 2022 | 21,599 | 118,686 (0%) | 0% | 240.1 | 5,186,157 | Common Stock |
| Pioneer Natural Resources Co. | Matthew M. Gallagher | Director | Sale of securities on an exchange or to another person at price $ 241.02 per share. | 01 Mar 2022 | 3,401 | 115,285 (0%) | 0% | 241.0 | 819,716 | Common Stock |
| Pioneer Natural Resources Co. | Matthew M. Gallagher | Director | Sale of securities on an exchange or to another person at price $ 229.64 per share. | 24 Feb 2022 | 11,833 | 145,929 (0%) | 0% | 229.6 | 2,717,342 | Common Stock |
| Pioneer Natural Resources Co. | Matthew M. Gallagher | Director | Sale of securities on an exchange or to another person at price $ 230.16 per share. | 24 Feb 2022 | 5,644 | 140,285 (0%) | 0% | 230.2 | 1,299,040 | Common Stock |
| Pioneer Natural Resources Co. | Matthew M. Gallagher | Director | Sale of securities on an exchange or to another person at price $ 230.17 per share. | 24 Feb 2022 | 2,523 | 157,762 (0%) | 0% | 230.2 | 580,729 | Common Stock |
| ITeos Therapeutics Inc | Matthew Gall | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 46.45 per share. | 27 Dec 2021 | 5,000 | 14,429 | - | 46.5 | 232,250 | Common Stock |
| ITeos Therapeutics Inc | Matthew Gall | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Oct 2021 | 14,429 | 42,388 | - | - | Stock Option (right to buy) | |
| ITeos Therapeutics Inc | Matthew Gall | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.16 per share. | 11 Oct 2021 | 14,429 | 19,429 | - | 6.2 | 88,883 | Common Stock |
| ITeos Therapeutics Inc | Matthew Gall | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 26.09 per share. | 16 Jun 2021 | 5,000 | 5,000 | - | 26.1 | 130,447 | Common Stock |
| Pioneer Natural Resources Co. | Matthew M. Gallagher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2021 | 1,456 | 160,285 (0%) | 0% | 0 | Common Stock | |
| Pioneer Natural Resources Co. | Matthew M. Gallagher | Director | Sale of securities on an exchange or to another person at price $ 156.29 per share. | 03 Mar 2021 | 45,216 | 201,752 (0%) | 0% | 156.3 | 7,066,718 | Common Stock |
| Pioneer Natural Resources Co. | Matthew M. Gallagher | Director | Sale of securities on an exchange or to another person at price $ 155.58 per share. | 03 Mar 2021 | 27,361 | 246,968 (0%) | 0% | 155.6 | 4,256,797 | Common Stock |
| Pioneer Natural Resources Co. | Matthew M. Gallagher | Director | Sale of securities on an exchange or to another person at price $ 154.52 per share. | 03 Mar 2021 | 23,227 | 158,829 (0%) | 0% | 154.5 | 3,589,129 | Common Stock |
| Pioneer Natural Resources Co. | Matthew M. Gallagher | Director | Sale of securities on an exchange or to another person at price $ 152.42 per share. | 03 Mar 2021 | 10,900 | 185,452 (0%) | 0% | 152.4 | 1,661,378 | Common Stock |
| Pioneer Natural Resources Co. | Matthew M. Gallagher | Director | Sale of securities on an exchange or to another person at price $ 151.76 per share. | 03 Mar 2021 | 4,000 | 196,352 (0%) | 0% | 151.8 | 607,036 | Common Stock |
| Pioneer Natural Resources Co. | Matthew M. Gallagher | Director | Sale of securities on an exchange or to another person at price $ 153.67 per share. | 03 Mar 2021 | 3,396 | 182,056 (0%) | 0% | 153.7 | 521,857 | Common Stock |
| Pioneer Natural Resources Co. | Matthew M. Gallagher | Director | Sale of securities on an exchange or to another person at price $ 157.56 per share. | 03 Mar 2021 | 1,400 | 200,352 (0%) | 0% | 157.6 | 220,584 | Common Stock |
| ITeos Therapeutics Inc | Matthew Gall | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 72,000 | 72,000 | - | - | Stock Option (Right to Buy) | |
| Expand Energy Corp. - Ordi... | Matthew M. Gallagher | Director | Grant, award, or other acquisition of securities at price $ 43.71 per share. | 22 Feb 2021 | 7,594 | 7,594 (0%) | 0% | 43.7 | 331,934 | Common Stock |
| Pioneer Natural Resources Co. | Matthew M. Gallagher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2021 | 272,052 | 272,052 (0%) | 0% | 0 | Common Stock | |
| Pioneer Natural Resources Co. | Matthew M. Gallagher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2021 | 2,277 | 274,329 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges